References
Key articles
Rosenberg AZ, Kopp JB. Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2017 Mar 7;12(3):502-17.Full text Abstract
Hogg R, Middleton J, Vehaskari VM. Focal segmental glomerulosclerosis: epidemiology aspects in children and adults. Pediatr Nephrol. 2007 Feb;22(2):183-6.Full text Abstract
Beaudreuil S, Lorenzo HK, Elias M, et al. Optimal management of primary focal segmental glomerulosclerosis in adults. Int J Nephrol Renovasc Dis. 2017 May 10;10:97-107.Full text Abstract
Bose B, Cattran D; Toronto Glomerulonephritis Registry. Glomerular diseases: FSGS. Clin J Am Soc Nephrol. 2014 Mar;9(3):626-32.Full text Abstract
Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guideline for glomerulonephritis. Jun 2012 [internet publication].Full text
Thomas DB, Franceschini N, Hogan SL, et al. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int. 2006 Mar;69(5):920-6.Full text Abstract
Deegens JK, Assmann KJ, Steenbergen EJ, et al. Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients? Neth J Med. 2005 Nov;63(10):393-8. Abstract
Reference articles
1. Rosenberg AZ, Kopp JB. Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2017 Mar 7;12(3):502-17.Full text Abstract
2. Kitiyakara C, Eggers P, Kopp JB. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis. 2004 Nov;44(5):815-25. Abstract
3. O'Shaughnessy MM, Hogan SL, Poulton CJ, et al. Temporal and demographic trends in glomerular disease epidemiology in the southeastern United States, 1986-2015. Clin J Am Soc Nephrol. 2017 Apr 3;12(4):614-23.Full text Abstract
4. Hogg R, Middleton J, Vehaskari VM. Focal segmental glomerulosclerosis: epidemiology aspects in children and adults. Pediatr Nephrol. 2007 Feb;22(2):183-6.Full text Abstract
5. Freedman BI, Hicks PJ, Bostrom MA, et al. Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans. Kidney Int. 2009 Apr;75(7):736-45.Full text Abstract
6. Haas M, Meehan SM, Karrison TG, et al. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis. 1997 Nov;30(5):621-31. Abstract
7. United States Renal Data System. Annual data report 2018: epidemiology of kidney disease in the United States. 2018 [internet publication].Full text
8. Beaudreuil S, Lorenzo HK, Elias M, et al. Optimal management of primary focal segmental glomerulosclerosis in adults. Int J Nephrol Renovasc Dis. 2017 May 10;10:97-107.Full text Abstract
9. Wei C, El Hindi S, Li J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011 Jul 31;17(8):952-60.Full text Abstract
10. Bose B, Cattran D; Toronto Glomerulonephritis Registry. Glomerular diseases: FSGS. Clin J Am Soc Nephrol. 2014 Mar;9(3):626-32.Full text Abstract
11. Mele C, Iatropoulos P, Donadelli R; the PodoNet Consortium. MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N Engl J Med. 2011 Jul 28;365(4):295-306. Abstract
12. Jefferson JA, Shankland SJ. The pathogenesis of focal segmental glomerulosclerosis. Adv Chronic Kidney Dis. 2014 Sep;21(5):408-16.Full text Abstract
13. Reidy K, Kaskel FJ. Pathophysiology of focal segmental glomerulosclerosis. Pediatr Nephrol. 2007 Mar;22(3):350-4.Full text Abstract
14. De Vriese AS, Sethi S, Nath KA, et al. Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach. J Am Soc Nephrol. 2018 Mar;29(3):759-74.Full text Abstract
15. Wickman C, Kramer H. Obesity and kidney disease: potential mechanisms. Semin Nephrol. 2013 Jan;33(1):14-22. Abstract
16. Wang CS, Greenbaum LA. Nephrotic syndrome. Pediatr Clin North Am. 2019 Feb;66(1):73-85. Abstract
17. Beer A, Mayer G, Kronbichler A. Treatment strategies of adult primary focal segmental glomerulosclerosis: a systematic review focusing on the last two decades. Biomed Res Int. 2016 Apr 7;2016:4192578.Full text Abstract
18. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guideline for glomerulonephritis. Jun 2012 [internet publication].Full text
19. Ponticelli C, Villa M, Banfi G, et al. Can prolonged treatment improve the prognosis in adults with focal segmental glomerulosclerosis? Am J Kidney Dis. 1999 Oct;34(4):618-25. Abstract
20. Matalon A, Valeri A, Appel GB. Treatment of focal segmental glomerulosclerosis. Semin Nephrol. 2000 May;20(3):309-17. Abstract
21. Korbet SM, Schwartz MM, Lewis EJ. Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis. 1994 Jun;23(6):773-83. Abstract
22. Alexopoulos E, Stangou M, Papagianni A, et al. Factors influencing the course and the response to treatment in primary focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2000 Sep;15(9):1348-56.Full text Abstract
23. Meyrier A. An update on the treatment options for focal segmental glomerulosclerosis. Expert Opin Pharmacother. 2009 Mar;10(4):615-28. Abstract
24. Cattran DC, Appel GB, Herbert LA, et al. A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int. 1999 Dec;56(6):2220-6.Full text Abstract
25. Ponticelli C, Rizzoni G, Edefonti A, et al. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int. 1993 Jun;43(6):1377-84.Full text Abstract
26. Meyrier A, Noel LH, Auriche P, et al. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Kidney Int. 1994 May;45(5):1446-56.Full text Abstract
27. Niaudet P. Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. J Pediatr. 1994 Dec;125(6 Pt 1):981-6. Abstract
28. Braun N, Schmutzler F, Lange C, et al. Immunosuppressive treatment for focal segmental glomerulosclerosis in adults. Cochrane Database Syst Rev. 2008 Jul 16;(3):CD003233.Full text Abstract
29. Cattran DC, Wang MM, Appel G, et al. Mycophenolate mofetil in the treatment of focal segmental glomerulosclerosis. Clin Nephrol. 2004 Dec;62(6):405-11. Abstract
30. Praga M, Hernandez E, Andres G, et al. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron. 1995;70(1):35-41. Abstract
31. Szczech LA, Edwards LJ, Sanders LL, et al. Protease inhibitors are associated with a slowed progression of HIV-related renal diseases. Clin Nephrol. 2002 May;57(5):336-41. Abstract
32. Atta MG, Gallant JE, Rahman MH, et al. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol Dial Transplant. 2006 Oct;21(10):2809-13.Full text Abstract
33. Ramachandran R, Kumar V, Rathi M, et al. Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience. Nephrol Dial Transplant. 2014 Oct;29(10):1918-24.Full text Abstract
34. Laurin LP, Nachman PH, Foster BJ. Calcineurin inhibitors in the treatment of primary focal segmental glomerulosclerosis: a systematic review and meta-analysis of the literature. Can J Kidney Health Dis. 2017 Feb 22;4:2054358117692559.Full text Abstract
35. Feld SM, Figueroa P, Savin V, et al. Plasmapheresis in the treatment of steroid resistant focal segmental glomerulosclerosis in native kidneys. Am J Kidney Dis. 1998 Aug;32(2):230-7. Abstract
36. Artero M, Biava C, Amend W, et al. Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med. 1992 Apr;92(4):375-83. Abstract
37. National Institute for Health and Care Excellence. Minimal change disease and focal segmental glomerulosclerosis in adults: rituximab. Nov 2016 [internet publication].Full text
38. Peters HP, van de Kar NC, Wetzels JF. Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature. Neth J Med. 2008 Nov;66(10):408-15. Abstract
39. Cho ME, Smith DC, Branton MH, et al. Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2007 Sep;2(5):906-13.Full text Abstract
40. Korbet SM, Schwartz MM, Lewis EJ. The prognosis of focal segmental glomerulosclerosis of adulthood. Medicine (Baltimore). 1986 Sep;65(5):304-11. Abstract
41. Rydell JJ, Korbet SM, Borok RZ, et al. Focal segmental glomerulosclerosis in adults: presentation, course, and response to treatment. Am J Kidney Dis. 1995 Apr;25(4):534-42. Abstract
42. Korbet SM. Clinical picture and outcome of primary focal segmental glomerulosclerosis. Nephrol Dial Transplant. 1999;14 Suppl 3:68-73.Full text Abstract
43. Thomas DB, Franceschini N, Hogan SL, et al. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int. 2006 Mar;69(5):920-6.Full text Abstract
44. Deegens JK, Assmann KJ, Steenbergen EJ, et al. Idiopathic focal segmental glomerulosclerosis: a favourable prognosis in untreated patients? Neth J Med. 2005 Nov;63(10):393-8. Abstract
45. Troyanov S, Wall CA, Miller JA, et al. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission. J Am Soc Nephrol. 2005 Apr;16(4):1061-8.Full text Abstract
46. Hickson LJ, Gera M, Amer H, et al. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation. 2009 Apr 27;87(8):1232-9. Abstract
Use of this content is subject to our disclaimer